- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about RXRX
Recent news which mentions RXRX
Cathie Wood's Ark Invest Books Profits On Hot AI Stock Palantir, Sells Bitcoin ETF Shares As BTC Starts 2025 On A Positive Note
January 04, 2025
From Benzinga
Nio, Unity Software And Other Big Stocks Moving Higher On Thursday
January 02, 2025
From Benzinga
Is Recursion Pharmaceuticals Stock a Millionaire Maker?
December 21, 2024
Tickers
RXRX
From Motley Fool
1 Artificial Intelligence (AI) Stock That Could Soar in 2025
December 21, 2024
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 11, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 10, 2024
From Benzinga
What's Going On With Recursion Pharmaceuticals Stock?
December 10, 2024
From Benzinga
An Investor's Guide to the Artificial Intelligence (AI) Value Chain
December 09, 2024
From Motley Fool
Ulta Beauty Posts Upbeat Results, Joins Asana, Lululemon, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Friday
December 06, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 04, 2024
From Benzinga
Berkshire Hathaway Isn't the Only Publicly Traded Company That Buys Stocks. These 3 Tech Giants Also Have Stock Portfolios.
December 04, 2024
From Motley Fool
XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
December 02, 2024
From Benzinga
(RXRX) - Analyzing Recursion Pharmaceuticals's Short Interest
November 28, 2024
Tickers
RXRX
From Benzinga
Jim Cramer: Reddit Is 'Fabulous,' Dow Is A 'Tough' One
November 27, 2024
From Benzinga
From Benzinga
2 Innovative Stocks That Could Deliver Outsize Returns
November 22, 2024
From Motley Fool
Nvidia Reveals 3.6% Stake In Applied Digital, Stock Soars
November 15, 2024
From Benzinga
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
November 11, 2024
From Benzinga
A Closer Look at 4 Analyst Recommendations For Recursion Pharmaceuticals
November 07, 2024
Tickers
RXRX
From Benzinga
Peering Into Recursion Pharmaceuticals's Recent Short Interest
November 04, 2024
Tickers
RXRX
From Benzinga
10 Health Care Stocks Moving In Monday's Pre-Market Session
November 04, 2024
From Benzinga
Is Recursion Pharmaceuticals a Millionaire-Maker Stock?
November 02, 2024
Tickers
RXRX
From Motley Fool
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
October 31, 2024
From Benzinga
3 Key Trends That Are Bullish for Recursion Pharmaceuticals Stock
October 26, 2024
Tickers
RXRX
From Motley Fool
Prediction: These 2 Stocks Could Soar in 2025
October 17, 2024
From Motley Fool
Cathie Wood Is Betting on This AI Stock: Is It a Buy?
October 15, 2024
Tickers
RXRX
From Motley Fool
Down 57% in 2024, Is Recursion Pharmaceuticals a Buy on the Dip?
October 15, 2024
Tickers
RXRX
From Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
October 08, 2024
From Motley Fool
2 Artificial Intelligence Stocks That Could Deliver Explosive Gains
October 07, 2024
From Motley Fool
2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk
September 29, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.